Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna

NCT00707174 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT00707174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00707174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna
Lead sponsor
University of Utah
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2005
Completion date
March 31, 2013
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, lentigo maligna